UNLIMITED TURBO BULL - BIOGEN IDEC | Market Closed - Euronext Paris 10:00:00 05/07/2024 pm IST | ||
| 0.77 EUR | +6.94% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 0.78 | +8.33% |
| 04/24/04 | 0.72 | -1.37% |
| 03/24/03 | 0.73 | -13.10% |
| 02/24/02 | 0.84 | -6.15% |
Real-time Euronext Paris
Last update July 05, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Société Générale
|
| 367YS | |
| ISIN | DE000SY2HUJ9 |
| Date issued | 01/07/2024 |
| Strike | 184.2 $ |
| Maturity | Unlimited |
| Parity | 50 : 1 |
| Emission price | 0.88 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.985 € |
|---|---|
| Lowest since issue | 0.71 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
225.6
USD
Average target price
283.2
USD
Spread / Average Target
+25.48%
- Stock Market
- Certificates
- 367YS Certificat
